BioWorld MedTech

May 20, 2016

Breakthrough techniques tap software to reveal causes of cardiac disease

PARIS – "If we can measure it, we can manage it" would have made a better title than "Imaging and Functional Assessment" for a session at EuroPCR 2016 presenting new techniques for cardiovascular diagnostics. Read More

Studies supportive of St. Jude's devices to treat HF, prevent stroke

Myriad opens patient portal as ACLU moves on gene data complaint

Efficacy comes to phase I cancer trials

With accelerated schedule, CFDA shoots for clarity

Other news to note

Daily M&A

Appointments and advancements

Product briefs

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 18, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Maintenance, man: Lilly’s phase III weight trial hits goals

BioWorld

Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...